# Marwan Berrada-Sounni

> Marwan Berrada-Sounni is the co-founder and CEO of Advanced NanoTherapies and founder and managing partner of T45 Labs in Santa Clara, California. Trained in mechanical engineering at the University of Minnesota and finance at McGill University, he previously led product development at Cleveland Clinic Foundation. His work spans invention, executive leadership, financing, and early-stage company development. In September 2026, Mitria Medical also named him CEO.

- **Role:** Co-founder and CEO at Advanced NanoTherapies; Founder and Managing Partner at T45 Labs; CEO at Mitria Medical
- **Organizations:** Advanced NanoTherapies, T45 Labs, Mitria Medical, VahatiCor, NuevoSono, MeeraMed, Cleveland Clinic Foundation, Global Cardiovascular Innovation Center, Shifamed
- **Education:** Bachelor’s degree in Mechanical Engineering, University of Minnesota, Master’s degree in Mechanical Engineering, University of Minnesota, MBA in Finance, McGill University
- **Known for:** Co-founded and leads Advanced NanoTherapies., Founded T45 Labs and serves as managing partner., Previously served as Senior Director of Product Development at Cleveland Clinic Foundation and on the commercialization funding committee of the Global Cardiovascular Innovation Center.

## Career timeline

- **2015** — Published an essay on commercialization and the role of leadership and relationships.
- **2020** — Led Advanced NanoTherapies as CEO when it announced a $5.3 million seed round in October.
- **2021** — Published essays on leadership and lessons from working with almost a dozen startups.
- **2022** — Advanced NanoTherapies announced a $7.2 million Series A in June; presented its product publicly at ICI Meeting in December.
- **2024** — Discussed incubators and early-stage financing with Tom Salemi on DeviceTalks Weekly on November 15.
- **2026** — Advanced NanoTherapies announced more than $31 million in Series B financing in June; Mitria Medical named him CEO in September.

## Achievements

- Co-founded and leads Advanced NanoTherapies.
- Founded T45 Labs and serves as managing partner.
- Previously served as Senior Director of Product Development at Cleveland Clinic Foundation and on the commercialization funding committee of the Global Cardiovascular Innovation Center.
- Contributed to multiple first-generation product launches.
- Named CEO of Mitria Medical in September 2026.

## Latest updates

- **2026-09** — Mitria Medical announced a partnership with T45 Labs and named Berrada-Sounni CEO alongside his T45 Labs role.
- **2026-06** — Advanced NanoTherapies announced an oversubscribed Series B financing totaling more than $31 million, co-led by an undisclosed strategic investor and S3 Ventures, with T45 Fund participation.

## Links

- Website: https://t45labs.com/
- LinkedIn: https://www.linkedin.com/in/marwaneberrada

---

Profile page: https://yespress.io/marwan-berrada-sounni
Published by YesPress — https://yespress.io
Last updated: 2026-10-25